InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Invus US Partners LLC. Director active across 1 company, notably Lexicon Pharmaceuticals, INC.. In total, 2 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €2.8m. Activity tracked since 1 August 2022. The latest transaction was disclosed on 5 August 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条